We are live on ! Find out more
GBT

Global Blood Therapeutics, Inc.
GBT

Delisted

GBT was delisted on the 4th of October, 2022.

Back to rankings

Fund managers haven’t disclosed any holdings of GBT yet.

GBT Hedge Fund Activity: Q1 2026 in Review

1 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Global Blood Therapeutics, Inc. (GBT) for Q1 2026, worth a combined $68 — unchanged from a quarter earlier.

Fund positioning in GBT was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Global Blood Therapeutics, Inc. (GBT) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $68 of Global Blood Therapeutics, Inc. stock for Q1 2026, unchanged quarter-over-quarter.
  • 0 funds opened new Global Blood Therapeutics, Inc. positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.